Atlas Trials

Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma

Clinical trial NCT02345408 · COMPLETED

Trial details

NCT number
NCT02345408
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2015-02-01
Primary completion
2020-05-06
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.